Surgepays Inc [SURG] stock is trading at $1.38, up 5.34%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SURG shares have gain 10.40% over the last week, with a monthly amount glided 2.99%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Surgepays Inc [NASDAQ: SURG] stock has seen the most recent analyst activity on March 13, 2024, when Maxim Group downgraded its rating to a Hold.
Surgepays Inc [SURG] stock has fluctuated between $1.05 and $4.61 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Surgepays Inc [NASDAQ: SURG] shares were valued at $1.38 at the most recent close of the market. An investor can expect a potential return of 624.64% based on the average SURG price forecast.
Analyzing the SURG fundamentals
Surgepays Inc [NASDAQ:SURG] reported sales of 83.60M for the trailing twelve months, which represents a drop of -86.04%. Gross Profit Margin for this corporation currently stands at 0.05% with Operating Profit Margin at -0.27%, Pretax Profit Margin comes in at -0.27%, and Net Profit Margin reading is -0.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.56 and Total Capital is -0.62. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2900 points at the first support level, and at 1.2000 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4700, and for the 2nd resistance point, it is at 1.5600.
Ratios To Look Out For
For context, Surgepays Inc’s Current Ratio is 6.24. In addition, the Quick Ratio stands at 4.70 and the Cash Ratio stands at 2.51. Considering the valuation of this stock, the price to sales ratio is 0.33, the price to book ratio is 0.82.
Transactions by insiders
Recent insider trading involved Cox Kevin Brian, CEO and Chairman of Board, that happened on Dec 03 ’24 when 35180.0 shares were sold. Chief Financial Officer, Evers Anthony George completed a deal on Dec 02 ’24 to sell 36666.0 shares. Meanwhile, Director KEVIN B COX bought 35180.0 shares on Dec 03 ’24.
